|D000856||Anorexia Nervosa NIH||0.71|
|D001068||Feeding and Eating Disorders NIH||0.45|
There is one clinical trial.
The COVID-19 pandemic has had detrimental effects on mental health. Individuals with eating disorders (EDs) are no exception, exhibiting increased symptoms and exacerbated feelings of isolation and anxiety. Across Canada, in-person outpatient services have been quickly replaced with virtual care, yet practitioners and patients have noted substantial challenges in adapting ED-related care virtually. Given the success of our previous research on Family-Based Treatment (FBT) for EDs, as well as the rapid transition to virtual care during COVID-19, there is an urgent need to adapt FBT to virtual formats and adopt it in the ED network. Using a multi-site case study with a mixed method pre/post design, this study aims to examine the implementation of virtual FBT (vFBT) as well as its impact within six ED programs in Ontario, building on the investigator's previous work, and further developing capacity in the system. The investigator will develop implementation teams at each site and provide a virtual training workshop on vFBT, with ongoing consultation during initial implementation. The investigator proposes to examine implementation success by studying fidelity to vFBT, as well as team and patient/family experience with virtual care, and patient outcomes. These findings for virtual care will not only be important in the COVID-19 context but are also vital in the North, where access to specialized services is extremely limited.
Description: Measured by a self-report questionnaire entitled Key Measure of Therapist Behaviours and Self-Efficacy in FBT (an indicator of therapist adherence to the key components of standard FBT within the vFBT model)Measure: Key components of FBT Time: Completed after session 4 of treatment, approximately 4 months
Description: Fidelity to vFBT, measured by FBT fidelity ratings of the first four sessions of vFBT using the FBT Fidelity and Adherence Check (experts in FBT fidelity rating will rate the recordings).Measure: Fidelity Time: Completed after the session 4 of treatment, approximately 4 months
Description: Experiences of the therapists, medical practitioners, administrators, and families in vFBT, qualitatively measured during semi-structured focus groupsMeasure: Qualitative experience of participants Time: Completed after session 4 of treatment, approximately 4 months
Description: Weight will be measured in kilograms.Measure: Change in Weight Time: At baseline before treatment, and at 1 week, 2 weeks, 3 weeks, and 4 weeks.
Description: The number of binge/purge episodes each week will be recorded by patients/their families.Measure: Change in Number of Binge/Purge Episodes Time: At baseline before treatment, and at 1 week, 2 weeks, 3 weeks, and 4 weeks.
Description: The Brief Individual Readiness to Change Scale will indicate how ready therapists feel they are to change. Higher scores indicate greater readiness to use research-based direct service techniques. Minimum score is 0, maximum score is 20.Measure: Therapists' Change in Readiness Time: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
Description: Their attitudes about evidence-based practice will be assessed using the Evidence Based Practice Attitudes Scale (EBPAS). The subscales include requirements, appeal, openness and divergence. The score for each subscale is created by computing a mean score for the items that load on a given subscale. Minimum score for each subscale is 0, maximum score for each subscale is 4.Measure: Therapists' Change in Attitudes about Evidence Based Practice Time: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
Description: Their confidence related to the intervention will be assessed by administering an adapted version of the Perceived Attributes of the Principles of Effectiveness Scale (MPAS). Higher scores are indicative of more favorable perception for adoption of the Family-Based Treatment model. The minimum score is 18, the maximum score is 90.Measure: Therapists' Change in Confidence related to the Intervention Time: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports